Clinical comparison of Hexabrix, iopamidol, and Urografin-60 in whole body computed tomography.
Urografin 60, iopamidol and Hexabrix were studied in patients undergoing body CT scans to examine the pharmacodynamics of these contrast agents. Immediately following rapid injection, the lower osmolality media, Hexabrix and iopamidol, gave greater aortic concentration of iodine in addition to higher concentrations in the liver and spleen. These two agents also provided significantly better renal enhancement than Urografin 60, with Hexabrix giving higher levels than iopamidol. The higher early vascular concentrations of Hexabrix and iopamidol and the relative absence of side effects due to hyperosmolality and decreased toxicity may have advantages in dynamic CT scanning.
D003287:Contrast Media / Q000378:metabolism*; D003973:Diatrizoate / Q000031:analogs & derivatives* / Q000378:metabolism*; D003974:Diatrizoate Meglumine / Q000378:metabolism*; D004338:Drug Combinations / Q000378:metabolism; D006801:Humans; D007463:Iodobenzoates / Q000378:metabolism*; D007479:Iopamidol; D007483:Iothalamic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D007485:Ioxaglic Acid; D014018:Tissue Distribution; D014057:Tomography, X-Ray Computed; D014283:Triiodobenzoic Acids / Q000378:metabolism*
D003287:Contrast Media; D004338:Drug Combinations; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D003973:Diatrizoate; D007483:Iothalamic Acid; D003974:Diatrizoate Meglumine; C027278:urovision; D007479:Iopamidol; D007485:Ioxaglic Acid